Evofem Biosciences, Inc. (EVFM)
OTCMKTS: EVFM · Delayed Price · USD
0.0178
+0.0036 (25.35%)
Apr 26, 2024, 1:48 PM EDT - Market open
Evofem Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.84 | 8.24 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Revenue Growth (YoY) | 104.23% | 1748.43% | - | - | - | - | - | - | - | - | Upgrade
|
| Cost of Revenue | 4.42 | 4.06 | 0.47 | 0.91 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Gross Profit | 12.42 | 4.19 | -0.02 | -0.91 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Selling, General & Admin | 71.51 | 137.86 | 86.55 | 30.51 | 34.23 | 6.1 | 5.46 | 7.64 | 4.42 | 2.97 | Upgrade
|
| Research & Development | 25.03 | 33.13 | 17.05 | 22.23 | 43.42 | 3.95 | 6.58 | 34.41 | 5.17 | 11.45 | Upgrade
|
| Other Operating Expenses | -2.09 | -4.73 | -2.08 | -19.99 | -0.15 | 0 | 0 | 0 | 0 | -0.05 | Upgrade
|
| Operating Expenses | 96.55 | 170.99 | 103.6 | 52.74 | 77.64 | 10.04 | 12.04 | 42.05 | 9.59 | 14.42 | Upgrade
|
| Operating Income | -84.12 | -166.8 | -103.62 | -52.74 | -77.64 | -10.04 | -12.04 | -42.05 | -9.59 | -14.42 | Upgrade
|
| Interest Income | 0.09 | 0.02 | 0.17 | 0.46 | 0.13 | 0.05 | 0.06 | 0.03 | 0.01 | 0 | Upgrade
|
| Interest Expense | -17.96 | 0 | 0 | 0 | 0 | 0 | 1.04 | 1.13 | 0.37 | 0.06 | Upgrade
|
| Other Expense / Income | 10.57 | 38.39 | 38.85 | 27.75 | 48.2 | -0.05 | 0.01 | 0.03 | 0.5 | 0.53 | Upgrade
|
| Pretax Income | -76.65 | -205.18 | -142.31 | -80.03 | -125.71 | -9.99 | -13.02 | -43.16 | -10.82 | -15.02 | Upgrade
|
| Income Tax | 0.04 | 0.02 | 0 | 0 | 0 | 0.05 | -0.01 | -0.03 | 0.36 | 0.01 | Upgrade
|
| Net Income | -76.7 | -205.19 | -142.31 | -80.03 | -125.71 | -9.99 | -13.02 | -43.16 | -10.82 | -15.02 | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change | 567.43% | 94.93% | 66.94% | 83.69% | 1017.70% | -14.76% | 0.74% | 0.16% | 3.05% | - | Upgrade
|
| EPS (Basic) | -164.59 | -2938.96 | -3973.23 | -3730.27 | -10763.01 | -9563.11 | -10618.76 | -35461.83 | -8904.72 | -12736.43 | Upgrade
|
| EPS (Diluted) | -164.59 | -2938.96 | -3973.23 | -3730.27 | -10763.01 | -9563.11 | -10618.76 | -35461.83 | -8904.72 | -12736.43 | Upgrade
|
| Free Cash Flow | -70.75 | -149.61 | -107.08 | -55.26 | -56.51 | -8.2 | -16.25 | -38.14 | -9.59 | -12.93 | Upgrade
|
| Free Cash Flow Per Share | -151.83 | -2142.80 | -2989.73 | -2575.67 | -4837.93 | -7847.81 | -13258.56 | -31337.34 | -7893.17 | -10962.91 | Upgrade
|
| Gross Margin | 73.78% | 50.81% | -4.93% | - | - | - | - | - | - | - | Upgrade
|
| Operating Margin | -499.64% | -2023.30% | -23234.08% | - | - | - | - | - | - | - | Upgrade
|
| Profit Margin | -455.53% | -2488.99% | -31907.85% | - | - | - | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -420.21% | -1814.73% | -24009.64% | - | - | - | - | - | - | - | Upgrade
|
| EBITDA | -93.6 | -133.14 | -66.86 | -44.99 | -29.59 | -9.95 | -11.98 | -42.02 | -9.58 | -14.4 | Upgrade
|
| EBITDA Margin | -555.89% | -1615.04% | -14990.13% | - | - | - | - | - | - | - | Upgrade
|
| Depreciation & Amortization | 1.02 | 1.02 | 0.3 | 0.26 | 0.26 | 0.05 | 0.07 | 0.06 | 0.02 | 0.07 | Upgrade
|
| EBIT | -94.61 | -134.17 | -67.16 | -45.25 | -29.85 | -9.99 | -12.05 | -42.08 | -9.6 | -14.47 | Upgrade
|
| EBIT Margin | -561.92% | -1627.45% | -15057.85% | - | - | - | - | - | - | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.